Gene · 54880
Papers3,332
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
981 to 1,000 of 3,332
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Targeting SAMHD1 with hydroxyurea in first-line cytarabine-based therapy of newly diagnosed acute myeloid leukaemia: Results from the HEAT-AML trial. | J Intern Med | 2022 | 35934913 | PubTator, text mining | PubMed |
| Cell-Free DNA Sequencing of Intraocular Fluid as Liquid Biopsy in the Diagnosis of Vitreoretinal Lymphoma. | Front Oncol | 2022 | 35928872 | PubTator, text mining | PubMed |
| PROBER identifies proteins associated with programmable sequence-specific DNA in living cells. | Nat Methods | 2022 | 35927480 | PubTator, text mining | PubMed |
| Single cell gene expression profiling of nasal ciliated cells reveals distinctive biological processes related to epigenetic mechanisms in patients with severe COVID-19. | Comput Biol Med | 2022 | 35926268 | PubTator, text mining | PubMed |
| [Rare differential diagnosis in bilateral gonalgia]. | Pathologie (Heidelb) | 2022 | 35925312 | PubTator, text mining | PubMed |
| Whole genome sequencing reveals the independent clonal origin of multifocal ileal neuroendocrine tumors. | Genome Med | 2022 | 35922826 | PubTator, text mining | PubMed |
| Genomic landscape of patients with FLT3-mutated acute myeloid leukemia (AML) treated within the CALGB 10603/RATIFY trial. | Leukemia | 2022 | 35922444 | PubTator, text mining | PubMed |
| Mcm2 hypomorph leads to acute leukemia or hematopoietic stem cell failure, dependent on genetic context. | FASEB J | 2022 | 35920299 | PubTator, text mining | PubMed |
| Mesenchymal tumor organoid models recapitulate rhabdomyosarcoma subtypes. | EMBO Mol Med | 2022 | 35916583 | PubTator, text mining | PubMed |
| Advancing precision medicines for ocular disorders: Diagnostic genomics to tailored therapies. | Front Med (Lausanne) | 2022 | 35911417 | PubTator, text mining | PubMed |
| X-linked genetic risk factors that promote autoimmunity and dampen remyelination are associated with multiple sclerosis susceptibility. | Mult Scler Relat Disord | 2022 | 35905688 | PubTator, text mining | PubMed |
| ASXL1 mutations predict inferior molecular response to nilotinib treatment in chronic myeloid leukemia. | Leukemia | 2022 | 35902731 | PubTator, text mining | PubMed |
| EBV-associated NK and T-cell lymphoid neoplasms. | Curr Opin Oncol | 2022 | 35900729 | PubTator, text mining | PubMed |
| The development of pevonedistat in myelodysplastic syndrome (MDS) and acute myeloid leukemia (AML): hope or hype? | Ther Adv Hematol | 2022 | 35898435 | PubTator, text mining | PubMed |
| Predictors of clonal evolution and myeloid neoplasia following immunosuppressive therapy in severe aplastic anemia. | Leukemia | 2022 | 35896822 | PubTator, text mining | PubMed |
| In Pursuit of Genetic Prognostic Factors and Treatment Approaches in Secondary Acute Myeloid Leukemia-A Narrative Review of Current Knowledge. | J Clin Med | 2022 | 35893374 | PubTator, text mining | PubMed |
| DNA methylation profiling improves routine diagnosis of paediatric central nervous system tumours: A prospective population-based study. | Neuropathol Appl Neurobiol | 2022 | 35892159 | PubTator, text mining | PubMed |
| Myelodysplastic Syndrome: Diagnosis and Screening. | Diagnostics (Basel) | 2022 | 35885487 | PubTator, text mining | PubMed |
| Beyond Pathogenic RUNX1 Germline Variants: The Spectrum of Somatic Alterations in RUNX1-Familial Platelet Disorder with Predisposition to Hematologic Malignancies. | Cancers (Basel) | 2022 | 35884491 | PubTator, text mining | PubMed |
| Targeted Next-Generation Sequencing of Thymic Epithelial Tumours Revealed Pathogenic Variants in KIT, ERBB2, KRAS, and TP53 in 30% of Thymic Carcinomas. | Cancers (Basel) | 2022 | 35884448 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/54880/papers?page=50